10: Remote toxicologic pathology. How Deciphex is accelerating the non-clinical drug development phase w/ Donal O'Shea.

Send us a text The guest of this episode is Donal O'Shea, the CEO, and founder of Deciphex. He has been active in the area of digital pathology essentially since its beginning. He worked in academia and founded several successful digital pathology start-ups before his current one. Deciphex, in contrast to most digital pathology companies, is focused on non-clinical pathology, and its mission is to facilitate the complete digitization of this space and to contribute to the faster turnaround t...